These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 993967)

  • 41. [On the bioavailability of hydrochlorothiazide and triamterene from commercial drugs (author's transl)].
    Knauf H; Möhrke W; Mutschler E; Völger KD
    Arzneimittelforschung; 1980; 30(6):1001-4. PubMed ID: 7191258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Transfer mechanisms and biologic availability of drugs].
    Med Monatsschr; 1975 Mar; 29(3):97-8. PubMed ID: 1124067
    [No Abstract]   [Full Text] [Related]  

  • 43. The importance of bioavailability to the pharmacist.
    Canada AT
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):346-8. PubMed ID: 1158541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Bioavailability and its significance in pharmacotherapy].
    Wiela-Hojeńska A; Orzechowska-Juzwenko K
    Pol Merkur Lekarski; 2003 Jan; 14(79):89-93. PubMed ID: 12712840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The general problem of drug bioavailability and its assessment in man.
    Smith RN
    Postgrad Med J; 1974 Nov; 50 Suppl 6():7-14. PubMed ID: 4459894
    [No Abstract]   [Full Text] [Related]  

  • 46. [Biologic availability of drugs].
    Stössel JP
    Tierarztl Prax; 1975; 3(1):109-12. PubMed ID: 1198586
    [No Abstract]   [Full Text] [Related]  

  • 47. Recognition of variable bioavailability as an international problem: a review of the earlier studies.
    Munro-Faure AD; Fowle AS; Fox J; Johnson BF; Lader S
    Postgrad Med J; 1974 Nov; 50 Suppl 6():14-8. PubMed ID: 4459882
    [No Abstract]   [Full Text] [Related]  

  • 48. Bioavailability and tolerance studies on acetylsalicylic acid suppositories.
    Borg KO; Ekenved G; Elofsson R; Sjögren J; Sölvell L
    Acta Pharm Suec; 1975; 12(5-6):491-8. PubMed ID: 1217502
    [No Abstract]   [Full Text] [Related]  

  • 49. [Relationship between bioavailability and clinical effect of chloramphenicol (author's transl)].
    Cid E; Henriquez A; Andrade A; Olguin R; Firmani E; Fuentes B
    J Pharm Belg; 1980; 35(4):273-6. PubMed ID: 7441476
    [No Abstract]   [Full Text] [Related]  

  • 50. [Determination of value and bioavailability of various heparin formulations (author's transl)].
    Messerschmidt W
    Arzneimittelforschung; 1980; 30(10):1623-5. PubMed ID: 7192097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Bioavailability study of 10184 CERM (author's transl)].
    Aiache JM; Pognat JF; Enreille A; Colombat A
    J Pharm Belg; 1981; 36(1):5-14. PubMed ID: 7229902
    [No Abstract]   [Full Text] [Related]  

  • 52. [Evaluation of the biologic availability of drugs under clinical conditions].
    Cepelák V; Mayer O; Cepeláková H; Vitous J; Petrlík M
    Cesk Farm; 1977 Mar; 26(2):59-64. PubMed ID: 577192
    [No Abstract]   [Full Text] [Related]  

  • 53. [Assay and bioavailability of vincamine (author's transl)].
    Jaminet F; Schneck G; Polastro E; Lejeune A
    J Pharm Belg; 1981; 36(6):421-5. PubMed ID: 7328483
    [No Abstract]   [Full Text] [Related]  

  • 54. [Bioavailability of two commercial phenytoin preparations (author's transl)].
    Yahaba Y; Obata N; Hidano F; Hori H; Unno K
    Seishin Shinkeigaku Zasshi; 1981; 83(9):582-96. PubMed ID: 7330117
    [No Abstract]   [Full Text] [Related]  

  • 55. [Relative bioavailability study of sulfinpyrazone after oral administration (author's transl)].
    Aiache JM; Lanquetin M; Hazard MC; Forichon J
    J Pharm Belg; 1981; 36(3):175-81. PubMed ID: 6894942
    [No Abstract]   [Full Text] [Related]  

  • 56. [Relative bioavailability study of sulfinpyrazine after oral administration (author's transl)].
    Aiache JM; Lanquetin M; Hazard MC; Forichon J
    J Pharm Belg; 1981; 36(3):182-6. PubMed ID: 7264864
    [No Abstract]   [Full Text] [Related]  

  • 57. Use of bioavailability data by practitioners. I: pitfalls in interpreting the data.
    Schumacher GE
    Am J Hosp Pharm; 1975 Aug; 32(8):639-42. PubMed ID: 1146833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Relative bioavailability study of sulfinpyrazone after oral administration (author's transl)].
    Aiache JM; Lanquetin M; Hazard MC; Forichon J
    J Pharm Belg; 1981; 36(2):81-90. PubMed ID: 7252762
    [No Abstract]   [Full Text] [Related]  

  • 59. Statistical problems in interpreting comparative bioavailability trials.
    Westlake WJ
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):342-5. PubMed ID: 1099025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bioavailability studies and the clinical pharmacologist: correlation of drug distribution with clinical effects.
    Ogilvie RI
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):349-54. PubMed ID: 1099026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.